• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《神经病理性疼痛问卷简表》阿拉伯语版本的编制与验证

Development and validation of Arabic version of the Neuropathic Pain Questionnaire-Short Form.

作者信息

Terkawi Abdullah Sulieman, Backonja Miroslav Misha, Abolkhair Abdullah, Almaharbi Sameeh, Joy Jaya, Foula Farida, Alswiti Mousa, Terkawi Yazzed Sulieman, Al-Zhahrani Tariq, Alghamdi Faris Saeed, Tsang Siny

机构信息

Department of Anesthesiology, University of Virginia, Charlottesville, VA, USA.

Department of Anesthesiology, King Fahad Medical City, Riyadh, Saudi Arabia.

出版信息

Saudi J Anaesth. 2017 May;11(Suppl 1):S53-S62. doi: 10.4103/sja.SJA_86_17.

DOI:10.4103/sja.SJA_86_17
PMID:28616004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5463567/
Abstract

INTRODUCTION

The Neuropathic Pain Questionnaire-Short Form (NPQ-SF) is the shortest diagnostic tool for the assessment of neuropathic pain, designed with the goal to differentiate between neuropathic and nonneuropathic pain. The aim of this study was to translate, culturally adapt, and validate the NPQ-SF questionnaire in Arabic.

METHODS

A systematic translation process was used to translate the original English NPQ-SF into Arabic. After the pilot study, the Arabic version was validated among patients with chronic pain in two tertiary care centers. Reliability of the translated version was examined using internal consistency, test-retest reliability, and intraclass correlation coefficient (ICC). We examined the validity of the Arabic NPQ-SF via construct validity, concurrent validity (associations with the numeric pain scale, Brief Pain Inventory, and Self-completed Leeds Assessment of Neuropathic Symptoms and Signs [S-LANSS]), face validity, and diagnostic validity. To investigate the responsiveness, the translated NPQ-SF questionnaire was administered twice among the same group of patients.

RESULTS

A total of 142 subjects (68 men, 74 women) were included in the study. Cronbach's α were 0.45 (95% CI: 0.29, 0.61) and 0.48 (95% CI: 0.33, 0.63), and the ICC was 0.78 (95% CI: 0.72, 0.85). The NPQ-SF was moderately to strongly associated with the S-LANSS questionnaire. Results showed our Arabic NPQ-SF to have good diagnostic accuracy, with area under the curve of 0.76 (95% CI: 0.67, 0.84). Results from the receiver operating characteristic analysis identified a cut-off score of ≥0.52 as the best score to distinguish between patients with or without neuropathic pain, which was higher than the recommended cut-off score (≥0) in the original study. With both sensitivity and specificity of 71%. Most patients found the NPQ-SF questionnaire to be clear and easy to understand.

CONCLUSION

Our translated version of NPQ-SF is reliable and valid for use, thus providing physicians a new tool with which to evaluate and diagnose neuropathic pain among Arabic-speaking patients.

摘要

引言

神经病理性疼痛问卷简表(NPQ-SF)是用于评估神经病理性疼痛的最短诊断工具,其设计目的是区分神经病理性疼痛和非神经病理性疼痛。本研究旨在对NPQ-SF问卷进行阿拉伯语翻译、文化调适及验证。

方法

采用系统翻译流程将原始英文NPQ-SF翻译成阿拉伯语。在预试验后,在两家三级护理中心的慢性疼痛患者中对阿拉伯语版本进行验证。使用内部一致性、重测信度和组内相关系数(ICC)检验翻译版本的信度。通过结构效度、同时效度(与数字疼痛量表、简明疼痛问卷和利兹神经病理性症状和体征自评量表[S-LANSS]的相关性)、表面效度和诊断效度检验阿拉伯语NPQ-SF的效度。为研究反应度,在同一组患者中对翻译后的NPQ-SF问卷进行了两次施测。

结果

本研究共纳入142名受试者(68名男性,74名女性)。克朗巴哈α系数分别为0.45(95%CI:0.29,0.61)和0.48(95%CI:0.33,0.63),ICC为0.78(95%CI:0.72,0.85)。NPQ-SF与S-LANSS问卷呈中度至高度相关。结果显示我们的阿拉伯语NPQ-SF具有良好的诊断准确性,曲线下面积为0.76(95%CI:0.67,0.84)。受试者工作特征分析结果确定区分有无神经病理性疼痛患者的最佳截断分数为≥0.52,这高于原始研究中推荐的截断分数(≥0)。灵敏度和特异度均为71%。大多数患者认为NPQ-SF问卷清晰易懂。

结论

我们翻译的NPQ-SF版本可靠且可用,从而为医生提供了一种评估和诊断阿拉伯语患者神经病理性疼痛的新工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48c2/5463567/c685c32e9b0d/SJA-11-53-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48c2/5463567/c685c32e9b0d/SJA-11-53-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48c2/5463567/c685c32e9b0d/SJA-11-53-g003.jpg

相似文献

1
Development and validation of Arabic version of the Neuropathic Pain Questionnaire-Short Form.《神经病理性疼痛问卷简表》阿拉伯语版本的编制与验证
Saudi J Anaesth. 2017 May;11(Suppl 1):S53-S62. doi: 10.4103/sja.SJA_86_17.
2
Development and validation of Arabic version of the douleur neuropathique 4 questionnaire.神经病理性疼痛4问卷阿拉伯语版本的开发与验证
Saudi J Anaesth. 2017 May;11(Suppl 1):S31-S39. doi: 10.4103/sja.SJA_97_17.
3
Development and validation of Arabic version of the Short-Form McGill Pain Questionnaire.《麦吉尔疼痛问卷简表阿拉伯语版的编制与验证》
Saudi J Anaesth. 2017 May;11(Suppl 1):S2-S10. doi: 10.4103/sja.SJA_42_17.
4
Neuropathic Pain Questionnaire and Neuropathic Pain Questionnaire-Short Form: Translation, Reliability, and Validation Study of the Turkish Version.神经性疼痛问卷和神经性疼痛问卷简表:土耳其语版本的翻译、信度和效度研究
Turk Neurosurg. 2019;29(5):683-688. doi: 10.5137/1019-5149.JTN.25466-18.1.
5
Development and validation of Arabic version of the pain catastrophizing scale.疼痛灾难化量表阿拉伯语版本的编制与验证
Saudi J Anaesth. 2017 May;11(Suppl 1):S63-S70. doi: 10.4103/sja.SJA_130_17.
6
Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya.将利兹神经病理性症状和体征评估量表(LANSS)翻译成阿拉伯语并进行文化调适,以供利比亚糖尿病患者使用。
Libyan J Med. 2017 Dec;12(1):1384288. doi: 10.1080/19932820.2017.1384288.
7
Psychometric properties of the Persian version of the neuropathic pain questionnaire.波斯语版神经性疼痛问卷的心理测量特性。
Disabil Rehabil. 2022 Oct;44(20):6065-6069. doi: 10.1080/09638288.2021.1955301. Epub 2021 Sep 9.
8
Psychometric and accuracy comparison of three commonly used questionnaires for the diagnosis of neuropathic pain.三种常用神经病理性疼痛诊断问卷的心理测量学及准确性比较
Saudi J Anaesth. 2021 Oct-Dec;15(4):409-418. doi: 10.4103/sja.sja_352_21. Epub 2021 Sep 2.
9
Cross-Cultural Validation of the Arabic Short-Form McGill Pain Questionnaire (SF-MPQ): Libyan Version in Patients With Musculoskeletal Pain.阿拉伯语简版麦吉尔疼痛问卷(SF-MPQ)的跨文化验证:利比亚版用于肌肉骨骼疼痛患者
Adv Rehabil Sci Pract. 2024 Feb 23;13:27536351241233917. doi: 10.1177/27536351241233917. eCollection 2024 Jan-Dec.
10
Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire.土耳其版自我管理的利兹评估神经性症状和体征问卷(S-LANSS)的有效性和可靠性。
Pain Med. 2010 Jul;11(7):1107-14. doi: 10.1111/j.1526-4637.2010.00837.x. Epub 2010 Apr 26.

引用本文的文献

1
Determinants of low satisfaction with life among wheelchair users with spinal cord injury in Egypt: a cross-sectional study.埃及脊髓损伤轮椅使用者生活满意度低的决定因素:一项横断面研究。
BMC Neurol. 2024 Oct 5;24(1):373. doi: 10.1186/s12883-024-03836-4.
2
Understanding social needs in pregnancy: Prospective validation of a digital short-form screening tool and patient survey.了解孕期的社会需求:数字简版筛查工具和患者调查的前瞻性验证
AJOG Glob Rep. 2023 Jan 6;3(1):100158. doi: 10.1016/j.xagr.2022.100158. eCollection 2023 Feb.
3
Validation of the Arabic Version of the Edmonton Symptom Assessment System.

本文引用的文献

1
Development and validation of Arabic version of the douleur neuropathique 4 questionnaire.神经病理性疼痛4问卷阿拉伯语版本的开发与验证
Saudi J Anaesth. 2017 May;11(Suppl 1):S31-S39. doi: 10.4103/sja.SJA_97_17.
2
Translation and linguistic validation of the self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) scale for use in a Libyan population.用于利比亚人群的自我完成的利兹评估神经性症状和体征(S-LANSS)量表的翻译和语言验证。
Pain Pract. 2013 Mar;13(3):198-205. doi: 10.1111/j.1533-2500.2012.00576.x. Epub 2012 Jun 22.
3
Modelling the prevalence and cost of back pain with neuropathic components in the general population.
埃德蒙顿症状评估系统阿拉伯语版的验证。
Int J Environ Res Public Health. 2023 Jan 31;20(3):2571. doi: 10.3390/ijerph20032571.
4
Possible Neuropathic Pain in Clinical Practice-Review on Selected Diagnostic Tools and Its Further Challenges.临床实践中可能存在的神经性疼痛——关于选定诊断工具及其进一步挑战的综述
Diagnostics (Basel). 2022 Dec 29;13(1):108. doi: 10.3390/diagnostics13010108.
5
Psychometric and accuracy comparison of three commonly used questionnaires for the diagnosis of neuropathic pain.三种常用神经病理性疼痛诊断问卷的心理测量学及准确性比较
Saudi J Anaesth. 2021 Oct-Dec;15(4):409-418. doi: 10.4103/sja.sja_352_21. Epub 2021 Sep 2.
6
Assessment of pain in patients with primary immune deficiency.原发性免疫缺陷患者的疼痛评估。
Saudi J Anaesth. 2021 Oct-Dec;15(4):377-382. doi: 10.4103/sja.SJA_87_20. Epub 2021 Apr 8.
7
The burden of chronic pain after major head and neck tumor therapy.头颈部肿瘤主要治疗后慢性疼痛的负担。
Saudi J Anaesth. 2017 May;11(Suppl 1):S71-S79. doi: 10.4103/sja.SJA_162_17.
8
Development and validation of Arabic version of the douleur neuropathique 4 questionnaire.神经病理性疼痛4问卷阿拉伯语版本的开发与验证
Saudi J Anaesth. 2017 May;11(Suppl 1):S31-S39. doi: 10.4103/sja.SJA_97_17.
在普通人群中建模具有神经性成分的背痛的流行率和成本。
Eur J Pain. 2009 Nov;13(10):1030-5. doi: 10.1016/j.ejpain.2008.12.003. Epub 2009 Feb 6.
4
Neuropathic pain: redefinition and a grading system for clinical and research purposes.神经性疼痛:用于临床和研究目的的重新定义及分级系统。
Neurology. 2008 Apr 29;70(18):1630-5. doi: 10.1212/01.wnl.0000282763.29778.59. Epub 2007 Nov 14.
5
painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain.疼痛检测问卷(painDETECT):一种用于识别背痛患者神经病理性成分的新型筛查问卷。
Curr Med Res Opin. 2006 Oct;22(10):1911-20. doi: 10.1185/030079906X132488.
6
Development and testing of a neuropathic pain screening questionnaire: ID Pain.一种神经性疼痛筛查问卷的开发与测试:ID疼痛问卷
Curr Med Res Opin. 2006 Aug;22(8):1555-65. doi: 10.1185/030079906X115702.
7
The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey.以神经性疼痛为主的慢性疼痛的流行病学。一项普通人群调查的结果。
J Pain. 2006 Apr;7(4):281-9. doi: 10.1016/j.jpain.2005.11.008.
8
Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).与神经或躯体损伤相关的疼痛综合征比较及新型神经性疼痛诊断问卷(DN4)的编制
Pain. 2005 Mar;114(1-2):29-36. doi: 10.1016/j.pain.2004.12.010. Epub 2005 Jan 26.
9
Neuropathic pain symptoms relative to overall pain rating.与总体疼痛评分相关的神经性疼痛症状
J Pain. 2004 Nov;5(9):491-7. doi: 10.1016/j.jpain.2004.09.001.
10
Neuropathic pain questionnaire--short form.神经性疼痛问卷——简表
Clin J Pain. 2003 Sep-Oct;19(5):315-6. doi: 10.1097/00002508-200309000-00005.